A comparison of treatment regimens for autoimmune hemolytic anemia: A network meta-analysis protocol
Deng, J.
Show abstract
Autoimmune hemolytic anemia (AIHA) is a rare blood disorder that result in the hemolysis of red blood cells (RBCs) due to the presence of autoantibodies in the serum. There are a variety of treatment regimens available for AIHA, including glucocorticoids, monoclonal antibody rituximab and splenectomy. We propose a network meta-analysis that investigates whether the use of different regimens can decrease adverse events, increase remission rate and improve lab results, including hemoglobin, RBC, reticulocyte counts, hematocrit and total bilirubin.
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Investigation of HLA susceptibility alleles and genotypes with hematological disease among Chinese Han population 93%
- Distribution, genetic polymorphism and genotype prediction of rhesus blood group antigens among the Kurdish population of Zakho, Kurdistan Region, Iraq 92%
- Association of ABO blood group with COVID-19 severity, acute phase reactants and mortality 92%
Similar papers in this journal
- Platelet dysfunction in immune thrombocytopenia: finding clinical subsets with platelet phenotypes 93%
- Exploring the role of Large Language Models (LLMs) in hematology: a systematic review of applications, benefits, and limitations 93%
- Delayed-Phase Thrombocytopenia in Patients of Coronavirus Disease 2019 (COVID-19) 92%
Similar papers in this journal
- Estimation of the Hemoglobin Glycation Rate Constant 93%
- Neural Network Predicts Need for Red Blood Cell Transfusion for Patients with Acute Gastrointestinal Bleeding Admitted to the Intensive Care Unit 93%
- Randomized controlled trial of convalescent plasma therapy against standard therapy in patients with severe COVID-19 disease 92%
Similar papers in this journal
- A mathematical model of flow-mediated coagulation identifies factor V as a modifier of thrombin generation in hemophilia A 90%
- Biomarkers of bleeding and venous thromboembolism in patients with acute leukemia 89%
- Coagulation factor XII, XI, and VIII activity levels and secondary events after first ischemic stroke 89%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.